Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro

Research output: Contribution to journal › Article › peer-review

85 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science